{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:17:44Z","timestamp":1787861864428,"version":"build-2784847793"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.heliyon.2023.e13397","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T12:05:02Z","timestamp":1675253102000},"page":"e13397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Thrombospondin-1 induction and VEGF reduction by proteasome inhibition"],"prefix":"10.1016","volume":"9","author":[{"given":"Fawzia","family":"Bardag-Gorce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carter","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imara","family":"Meepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Ferrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"Hoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Niihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e13397_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108457","article-title":"Corneal angiogenic privilege and its failure","volume":"204","author":"Di Zazzo","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.heliyon.2023.e13397_bib2","article-title":"Limbal stem cell deficiency: current treatment options and emerging therapies","volume":"2016","author":"Haagdorens","year":"2016","journal-title":"Stem Cell. Int."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e13397_bib3","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1167\/iovs.03-0940","article-title":"Roles of thrombospondin-1 and -2 in regulating corneal and Iris angiogenesis","volume":"45","author":"Cursiefen","year":"2004","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e13397_bib4","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/jcmm.12164","article-title":"A systems biology view of blood vessel growth and remodeling","volume":"18","author":"Logsdon","year":"2014","journal-title":"J. Cell Mol. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e13397_bib5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jtos.2019.06.001","article-title":"Thrombospondin-1 in ocular surface health and disease","volume":"17","author":"Foulsham","year":"2019","journal-title":"Ocul. Surf."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e13397_bib6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jtos.2019.04.002","article-title":"MicroRNAs in the cornea: role and implications for treatment of corneal neovascularization","volume":"17","author":"Mukwaya","year":"2019","journal-title":"Ocul. Surf."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e13397_bib7","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.3390\/ijms19103191","article-title":"Thrombospondin-1 is necessary for the development and repair of corneal nerves","volume":"19","author":"Tatematsu","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2023.e13397_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108363","article-title":"Corneal neovascularization","volume":"202","author":"Nicholas","year":"2021","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e13397_bib9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jtos.2014.12.003","article-title":"Carrier-free cultured autologous oral mucosa epithelial cell sheet (CAOMECS) for corneal epithelium reconstruction: a histological study","volume":"13","author":"Bardag-Gorce","year":"2015","journal-title":"Ocul. Surf."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e13397_bib10","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1167\/iovs.11-9293","article-title":"Expression of angiogenesis-related factors in human corneas after cultivated oral mucosal epithelial transplantation","volume":"53","author":"Chen","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e13397_bib11","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1084\/jem.20092277","article-title":"Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes","volume":"208","author":"Cursiefen","year":"2011","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e13397_bib12","doi-asserted-by":"crossref","first-page":"432","DOI":"10.21037\/atm-21-4927","article-title":"Melatonin exerts anti-angiogenic and anti-inflammatory effects in alkali-burned corneas","volume":"10","author":"Meng","year":"2022","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e13397_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/71517","article-title":"Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1","volume":"6","author":"Jim\u00e9nez","year":"2000","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e13397_bib14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jtos.2018.07.005","article-title":"The immunoregulatory role of corneal epithelium-derived thrombospondin-1 in dry eye disease","volume":"16","author":"Tan","year":"2018","journal-title":"Ocul. Surf."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e13397_bib15","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.bbrc.2004.01.146","article-title":"Thrombospondin-1 accelerates wound healing of corneal epithelia","volume":"315","author":"Uno","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"639","key":"10.1016\/j.heliyon.2023.e13397_bib16","doi-asserted-by":"crossref","first-page":"eaba3880","DOI":"10.1126\/scisignal.aba3880","article-title":"BMP-1 disrupts cell adhesion and enhances TGF-\u03b2 activation through cleavage of the matricellular protein thrombospondin-1","volume":"13","author":"Anastasi","year":"2020","journal-title":"Sci. Signal."},{"issue":"20","key":"10.1016\/j.heliyon.2023.e13397_bib17","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.3748\/wjg.v17.i20.2558","article-title":"Proteasome inhibitor treatment in alcoholic liver disease","volume":"17","author":"Bardag-Gorce","year":"2011","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e13397_bib18","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1167\/iovs.05-1305","article-title":"Unique distribution of thrombospondin-1 in human ocular surface epithelium","volume":"47","author":"Sekiyama","year":"2006","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e13397_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00109-011-0805-8","article-title":"Bortezomib represses HIF-1\u03b1 protein expression and nuclear accumulation by inhibiting both PI3K\/Akt\/TOR and MAPK pathways in prostate cancer cells","volume":"90","author":"Befani","year":"2012","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.heliyon.2023.e13397_bib20","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1182\/blood-2007-11-120576","article-title":"Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1","volume":"111","author":"Shin","year":"2008","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e13397_bib21","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.bbamcr.2011.08.018","article-title":"CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1\u03b1","volume":"1813","author":"Yoon","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e13397_bib22","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3233\/XST-160571","article-title":"Bortezomib sensitizes esophageal squamous cancer cells to radiotherapy by suppressing the expression of HIF-1\u03b1 and apoptosis proteins","volume":"24","author":"Wang","year":"2016","journal-title":"J. X Ray Sci. Technol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e13397_bib23","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1158\/0008-5472.CAN-06-2722","article-title":"Suppression of the hypoxia-inducible factor-1 response in cervical carcinoma xenografts by proteasome inhibitors","volume":"67","author":"Birle","year":"2007","journal-title":"Cancer Res."},{"issue":"21","key":"10.1016\/j.heliyon.2023.e13397_bib24","first-page":"10280","article-title":"Targeting hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumab","volume":"5","author":"Falchook","year":"2014","journal-title":"Clin. Trial Oncotarg."},{"key":"10.1016\/j.heliyon.2023.e13397_bib25","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s13770-013-1103-z","article-title":"Microarray analysis of oral mucosal epithelial cell sheet","volume":"10","author":"Bardag-Gorce","year":"2013","journal-title":"Tiss. Engin. Regen. Med."},{"issue":"Pt 3","key":"10.1016\/j.heliyon.2023.e13397_bib26","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1042\/bj3180959","article-title":"Binding and degradation of thrombospondin-1 mediated through heparan sulphate proteoglycans and low-density-lipoprotein receptor-related protein: localization of the functional activity to the trimeric N-terminal heparin-binding region of thrombospondin-1","volume":"318","author":"Chen","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.heliyon.2023.e13397_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108446","article-title":"Repurposing bortezomib for choroidal neovascularization treatment via antagonizing VEGF-A and PDGF-D mediated signaling","volume":"204","author":"Liu","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.heliyon.2023.e13397_bib28","doi-asserted-by":"crossref","first-page":"12485","DOI":"10.1073\/pnas.171460498","article-title":"Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor","volume":"98","author":"Rodriguez-Manzaneque","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.heliyon.2023.e13397_bib29","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/jcp.20904","article-title":"Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1)","volume":"210","author":"Greenaway","year":"2007","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.heliyon.2023.e13397_bib30","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1096\/fj.09-131649","article-title":"Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level","volume":"23","author":"Zhang","year":"2009","journal-title":"Faseb. J."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e13397_bib31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/13543784.2022.2009455","article-title":"Atezolizumab-bevacizumab plus Y-90 TARE for the treatment of hepatocellular carcinoma: preclinical rationale and ongoing clinical trials","volume":"31","author":"Di Federico","year":"2022","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.heliyon.2023.e13397_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.803133","article-title":"Predictive biomarkers for checkpoint inhibitor-based immunotherapy in hepatocellular carcinoma: where do we stand?","volume":"11","author":"Rizzo","year":"2021","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e13397_bib33","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1080\/17474124.2021.1973431","article-title":"First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challenges","volume":"15","author":"Rizzo","year":"2021","journal-title":"Expet Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.heliyon.2023.e13397_bib34","article-title":"Corneal thinning following bevacizumab intrastromal injection for the treatment of idiopathic lipid keratopathy","volume":"27","author":"Sun","year":"2022","journal-title":"Case Rep. Am. J. Ophthalmol. Case Rep."},{"key":"10.1016\/j.heliyon.2023.e13397_bib35","doi-asserted-by":"crossref","DOI":"10.1177\/09603271221084674","article-title":"The effects of subconjunctival bevacizumab, ranibizumab, and aflibercept on corneal neovascularization","volume":"41","author":"Eski","year":"2022","journal-title":"Hum. Exp. Toxicol."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e13397_bib36","first-page":"865","article-title":"Bevacizumab in high-risk corneal transplantation: a pilot multicenter prospective randomized control trial","volume":"129","author":"H Dohlman","year":"2022","journal-title":"Random. Contr. Trial Ophth."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023006047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023006047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:48:31Z","timestamp":1776876511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023006047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2405844023006047"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e13397","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombospondin-1 induction and VEGF reduction by proteasome inhibition","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e13397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e13397"}}